New eye scanner software could sharpen diagnosis of macular degeneration
NCT ID NCT02827071
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new software called AngioScan, used with an already-approved eye camera, to see if it can take better pictures of the back of the eye. Researchers looked at 150 patients with retinal problems like macular degeneration. The goal was to find out if the software helps doctors see and diagnose eye diseases more clearly.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AngioScan angiography software (used with an FDA-approved OCT camera)
What this could lead to
If successful, this software could help doctors get clearer images of the eye, potentially leading to better diagnosis and treatment of retinal diseases.
What could go wrong
The software is not yet FDA-approved, and the study was terminated early, so results may be limited. It is a small, early-stage imaging study, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stein Eye Institute/Geffen School of Medicine
Los Angeles, California, 90095, United States